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Abstract 
Introduction: Altitude exposure and acclimatization is associated with a rapid increase in 
hematocrit. The time course and contribution of the red cell volume expansion is not clear. 
The purpose of the present meta-analysis is to explore how much altitude exposure is required 
to induce polycythemia in healthy lowlanders.  
Methods: A systematic review of 66 published papers (including 447 volunteers) identified 
through literature search. We performed mixed-model random-effects meta-analysis and 
Monte-Carlo simulation on the extracted data.  
Results: 1) that red cell volume expansion for a given duration of exposure is dependent on 
altitude (P<0.0001) i.e. that the increase in red cell volume was accelerated at higher altitudes, 
and 2) that the extent of the erythropoietic response depends on the initial red cell volume 
(P<0.0001). It appears that exposure time must exceed 2 weeks at an altitude of more than 
4,000 m to exert a statistically significant effect. At lower altitudes, longer exposure times are 
needed with altitudes below 3,000 m not yielding an increase within 4 weeks.  
Conclusion: Red cell volume response to hypoxia is generally slow although it accelerates 
with altitude. This, in combination with a dependency on initial red cell volume, suggests that 
e.g. athletes may need to spend more time at altitude to see an effect on red cell volume than 
commonly recommended.  
 
Keywords: altitude training, hemoglobin mass, hypoxia, systematic review.  
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[Paragraph Number 1.]  
Introduction 
Hypoxia leads to stabilization of the Hypoxia Inducible Factor-2 (HIF-2) system in the renal 
peritubular cells which subsequently binds to the hypoxic response element on the (Epo) gene 
and induces synthesis and release of Epo 11. As a results, plasma Epo concentrations start to 
increase after approximately two hours of hypoxic exposure 5. As exposure continues a zenith 
is reached after 3-4 days, where after plasma Epo concentration gradually decreases to 
stabilize slightly above sea level values 3,19,25. 
[Paragraph Number 2.]  
The primary function of EPO is to stimulate the maturation of reticulocytes in the bone 
marrow. Furthermore, permanent residence at altitude is associated with an augmented total 
red cell volume (RCV) 25 which has led to the persisting paradigm that extended hypoxic 
exposure induces polycythemia in lowlanders. Nevertheless, the Epo response to hypoxia 
does not necessarily translate into an elevated RCV 1,23. In fact, the initial increase in 
hematocrit at altitude is entirely the result of a plasma volume contraction that occurs within 
the first hours/days of exposure 22. In contrast, the time course of RCV expansion and the 
dependency on the degree of hypoxia remain largely unknown. This is related to the 
inconvenience of exposing a sufficient subject number to different altitudes for a prolonged 
time. To overcome this problem we conducted a meta-analysis of published experiments and 
explored the duration and degree of altitude exposure required to induce polycythemia in 
healthy low-landers. 
 
[Paragraph Number 3.]  
Methods 
Search strategy 
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This meta-analysis is based on papers retrieved from the web-based data bases PubMed and 
Web of Science (See selection process and reference list, Supplemental Digital Content). Up 
to January 2012, we introduced the following key words and Boolean connectors. 
(altitude OR hypoxia) AND acclimatization AND (haemoglobin mass OR 
hemoglobin mass OR haematocrit OR hematocrit OR red blood cell mass OR red 
blood cell volume OR blood volume OR plasma volume) 
The search was refined by applying the limits Humans and All adult: +19 years in PubMed 
and searching within the subject areas of Physiology, Respiratory system, Cardiovascular 
system cardiology, Sport Sciences and Hematology in the Web of Science. This initial search 
generated a group of 6,775 references that were transferred to an EndNote (Thomson Reuters, 
New York, USA) data base.  
[Paragraph Number 4.]  
In EndNote, duplicate references were removed. From the remaining references in vitro or 
animal studies, reviews and conference proceedings were eliminated. The abstracts of the 446 
remaining papers were then independently evaluated by two researchers and papers not 
fulfilling the eligibility criteria (see below) were removed. Disagreements were resolved by 
involving the rest of the research team. At the end of this process we selected 53 papers. 
Subsequently, we built a reference map for each paper and obtained the references cited in or 
citing the initial 53 papers. This step retrieved a new group of 3185 papers (1503 backward 
and 1682 forward references) and the same process detailed above and in figure 1 was 
repeated. Finally, 66 papers were selected to be included in the meta-analysis, see 
Supplemental Digital Content. 
 
[Paragraph Number 5.]  
Eligibility criteria 
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Any study on healthy humans reporting data before and after a period of exposure to hypoxia 
(normobaric or hypobaric, continuous or intermittent) for blood compartments (plasma 
volume, RCV or blood volume) or total haemoglobin mass was eligible. Only investigations 
using direct methods of measurement (Evans blue, CO-rebreathing, radioiodinated albumin or 
red-brilliant dilution) were accepted. Studies on high altitude natives, reviews, conference 
proceedings, editorials and letters to the editor were rejected. Studies in which the 
experimental procedures included any intervention susceptible of affecting any blood 
compartment, other than physical activity, were eliminated as well. 
 
[Paragraph Number 6.]  
Data extraction 
The data were transferred into an Excel file by two researchers working independently, and 
subsequently compared to avoid error. When data were extracted from figures, the mean 
between the values obtained by the two researchers was taken. 
When the degree of altitude was not constant a time-weighted average was calculated.  
 
 
where Dur.i and Alt.i are the duration and altitude at step “i”. So for, e.g., a stepwise accent to 
Mt. Everest 20 the average altitude is derived as [1 day x 3,800 m + 5 days x 4,500 m + 5 days 
x 5,000 m + 2 days x 5,500 + ... etc]/36 days = 5,720 m. If only SEMs were reported, variance 
was calculated from sample size and SD, otherwise variance was calculated from SD alone. 
 
[Paragraph Number 7.]  
Statistical analysis 
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Mixed-model random-effects meta-regression was performed (SAS 9.2, SAS institute) on log 
response ratios 10. The log response ratio was calculated as the logarithm to the change in 
RCV i.e. the post value divided by the pre/control value. We chose RCV as our effect 
parameter due to the linear relationship with haemoglobin mass, whereas hematocrit and 
hemoglobin concentration was excluded for their dependency on plasma volume. If red cell 
volume was missing it was derived from the linear relationship between hemoglobin mass and 
RCV. This relationship was obtained from 13 studies (n=28) where both hemoglobin mass 
and RCV were reported (RCV = hemoglobin mass * 2.899, P < 0.0001). In general, none of 
the included studies reported confidence intervals or standard deviations on the change in 
RCV, rather SD (or SEM) was reported on the pre and post values separately. Variance was 
therefore corrected as proposed for cross-over trials 4. P-values below 0.05 were considered 
statistically significant. 
 
[Paragraph Number 8.]  
Analysis and results 
Overall subject characteristics are reported in Table 1. In total this analysis reports data from 
447 volunteers of which 376 were male and 71 female. RCV increases versus exposure time 
and altitude are shown in Fig. 1. On average, the RCV increase per week was 
49±240ml/week. 
 
[Paragraph Number 9.]  
Heterogeneity 
Due to the inclusion of papers spanning different methodologies (plasma dye dilution, carbon 
monoxide re-breathing or radioactive albumin labeling), altitudes (from 1,300 to 6,000 meters 
above sea-level), exposure times (from 1 day to 1 year), intermittent hypoxia (range 1-21 
h/day, mean 12±5 h/day) and normobaric hypoxia, dataset heterogeneity is a potential 
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confounder that might affect outcome of the analysis (Table 2). We tested for inhomogeneity 
in with mixed-model regression analysis and found no significant effect of the method 
(P=0.94), normobaric versus hypobaric hypoxia (P=0.68), continuous versus intermittent 
hypoxia (P=0.14), or exercise versus no exercise (P=0.23). Thus, because of the absence of 
significant effect, for the main analysis all data was included. 
 
[Paragraph Number 10.]  
Effect of exposure altitude and duration 
For clarity of presentation, data was divided into both altitude and duration quartiles (see Fig. 
2). The random effects model yielded significant main effects for both altitude and duration 
(both p<0.0001, Fig. 1), however, there was also a significant interaction effect (p<0.0001) 
and therefore the main effects (p-values indicated) should be interpreted with caution. It 
appears that exposure time must exceed at least 2 weeks at an altitude of more than 4,000 m 
to exert a significant effect. At lower altitudes, even longer exposure times are needed with 
altitudes below 3,000 m not yielding a statistically significant result within 4 weeks. 
We subsequently performed Monte-Carlo simulation to estimate the required exposure time 
for an increase in RCV at different altitudes. We entered mean pre and post exposure RCV 
values with standard deviations along with exposure time into a custom written Matlab 
(MathWorks, Natick, MA) procedure. From these distributions we randomly drew paired 
numbers and calculated change in RCV as a function of time. The results of the simulation are 
presented in Table 3. There is an accelerating effect of increasing altitude so that, e.g. 
reaching a 10% increase at 2,000 m will take 42 to 145 days while at 3,500 m this can be 
achieved between 23 and 51 days. 
 
[Paragraph Number 11.]  
Effect of initial red cell volume 
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Finally, we examined the effect of the initial red cell volume on the RCV response to hypoxic 
exposure. To obtain a homologous dataset we restricted the analysis to the special case of 
exposure between 3,000 and 3,500 m and more than 7 days of stay. The random-effects model 
showed a highly significant effect of initial RCV with a high initial RCV showing less 
increase compared to low initial RCV (P<0.0001, Fig. 3). 
 
[Paragraph Number 12.]  
Discussion 
The main findings of the meta-analysis and Monte Carlo simulations are that altitude 
exposure must exceed 2 weeks at an altitude of > 4,000 m to exert a significant effect on 
RCV. At lower altitudes, even longer exposure is required with altitudes below 3,000 m not 
yielding a statistically significant result within 4 weeks. Thus we established an altitude dose-
response curve indicating that the hypoxia-induced response in RCV may be slower than 
widely expected 26. 
 
[Paragraph Number 13.]  
Variation in RCV response 
We find that the average RCV increase per week for our data is 49±240ml/week which, on 
average, is in accordance with previous findings with EPO administration 2. While we find the 
large variation surprising, similar results may be found in the plasma Epo response to altitude. 
Ge and co-workers reported that the increase in plasma Epo after 24 hours at 2800 m varied 
markedly among individuals (n=48), ranging from -41 to 400% which seemed mainly 
governed by upstream factors related to renal parenchymal PO2 although genetic factors 
cannot be ruled out . Although variations in both RCV and the Epo response to altitude are 
observed these do not seem to be interlinked. In a retrospectively analysis of the Levine data , 
Kommentar [PR1]: Carsten, kan du 
skrive et eller andet om variation i EPO 
respons a la: 
We note the Chapman paper (1998) that 
retrospectively analyse the Levine data, 
indicate no correlation between EPO 
response and erythropoietic response and 
points to inter-individual variation in 
responsiveness  
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no correlation between the EPO response and erythropoietic response was observed and 
points to inter-individual variation in responsiveness  
 
our Our finding that >35% of the reported data corresponds to RCV increases per week in 
excess of 50ml/week is in accordance with Sawka et al 22 which also states that in altitude 
studies RCV often increase with more than by 50 ml/week. It is intriguing that, in some 
studies, an increase in RCV is observed within days of exposure to an altitude that did not 
stimulate polycythemia even after weeks in other studies (Fig. 1). This suggests a substantial 
inter-individual variation 23. Other candidates that could lead to variation include the use of 
different measurement techniques or of the application of continuous versus intermittent or 
normobaric versus hypobaric hypoxia (Table 2). Although there was no systematic effect 
observed when these parameters were entered as a factors, the inclusion of results obtained 
with different methods may have increased the variance and reduced the power of the 
analysis. Some evidence suggests slightly different physiological responses to hypobaric vs 
normobaric hypoxia in regards to ventilation and acute mountain sickness 15,18. This does, 
however, not seem to be the case for the RCV response, which is in line with the observation 
that the Epo response to hypobaric and normobaric hypoxia is also similar 6.  
 
[Paragraph Number 14.]  
Effect of initial RCV 
One factor that had an effect on the response to altitude exposure was the initial RCV. In this 
context, we recently failed to observe an increase in RCV after 16 hours/day at 3,000 m for 4 
weeks 23. From the analysis we would expect an 5-10% increase in RCV and we speculated 21 
that the absence of an increase in RCV could be related to high initial hemoglobin mass of the 
included elite athletes that was at the upper end of physiological range (Table 1). The present 
meta-analysis supports this approach (Fig. 3). Whereas it is intuitively straightforward that an 
Formatiert: Schriftart: Times New
Roman, 12 Pt.
Kommentar [CL5]: Individual 
variation in response to altitude training. 
Chapman RF, Stray-Gundersen J, 
Levine BD 
 
Formatiert: Schriftart: Times New
Roman, 12 Pt., Nicht Fett
Formatiert: Schriftart: Times New
Roman, 12 Pt.
Formatiert: Englisch (Großbritannien)
Formatiert: Schriftart: 11 Pt., Englisch
(Großbritannien)
Kommentar [L6]: Det her kunne man 
vel slette. 
Formatiert: Schriftart: 11 Pt., Englisch
(Großbritannien)
10 
 
upper limit to RCV expansion must exist, the physiological mechanism governing such a limit 
is not as easily straightforwardexplained. Although the current meta-analysis indicates that a 
high initial RCV limits a further expansion at altitude, the study by Kapoor et al. 13 points out 
that despite a high baseline level, an increase in RCV can still occur if duration and altitude 
are sufficient (Fig. 1). Thus, to what extent a physiological upper limit to RCV exists is not 
clear from this meta-analysis. However, 17.5 g of hemoglobin per kg bodyweight has been 
reported in World and Olympic Champion cross country skiers 12, which is markedly higher 
than values reported in healthy but un-trained high altitude Peruvians 7. Thus, the upper limit 
is likely not reached by altitude exposure alone. It should thus be considered that a RCV 
ceiling may not relate to increased oxygen carrying capacity of blood alone, but could also be 
related to an upper limit in blood volume and to blood pressure regulation. 
 
[Paragraph Number 15.]  
Another explanation for the finding that a high initial RCV attenuates the further increase 
with hypoxic exposure could be the statistical phenomenon of regression toward the mean. 
Regression toward the mean may occur when RCV is high on its first measurement, because 
it will by chance tend to be closer to the average on a second measurement. To avoid drawing 
wrong conclusions from this meta-analysis (particular Fig. 3), the possibility of regression 
toward the mean should be considered. However, since regression toward the mean is not 
based on cause and effect, but rather on random error in a natural distribution around a mean, 
we cannot exclude any underlying physiological mechanisms influencing the effect of initial 
RCV on erythropoietic response to altitude exposure. 
 
[Paragraph Number 16.]  
Is altitude exposure relevant for athletes? 
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In order to increase RCV and thereby also sea level exercise performance, it is recommended 
that athletes reside in normobaric or hypobaric hypoxia corresponding to an altitude of 2,500 - 
3,000 m for a minimum of 14 hours/day for 3 weeks 26. The effect of the initial RCV (Fig. 3) 
and the considerable time required to establish a RCV response to medium altitude exposure 
(Table 3) is of relevance for athletes considering engaging into altitude training. Assuming 
that anecdotal reports of athletes coping bad with altitudes above 3,000 m (increased recovery 
period after exercise, poor quality of sleep etc.) are correct, then altitudes above this threshold 
should be avoided. Since only studies in athletes which have demonstrated > 5% increase in 
hemoglobin mass following altitude training generally report an increase in exercise 
performance 21, it is recommended that athletes should spend sufficient time at altitude to 
achieve a corresponding increase in hemoglobin mass. A gain in hemoglobin mass of 7.5% 
requires between 35 and 56 days of live-high train-low or 25 to 47 days of continuous 
exposure at 2,500 m to achieve a > 95 % probability for an increase (Table 3). This is further 
extended by a high initial RCV which results in lower probability for a further increase to 
occur. This questions the feasibility of altitude training for elite athletes, and the potential 
gains by altitude training, at least in athletes with a high RCV starting point, should therefore 
be carefully reconsidered. 
 
[Paragraph Number 17.]  
Publication bias  
We found some indications for publication bias in the tendency for studies with small changes 
and large variations to be missing from the analysis. Thus, we cannot exclude that the analysis 
over-estimates the positive outcome. On the other hand, almost 40% of the included data 
points reported negative findings and 50% of the data points reported less than 2.5% increase.  
 
[Paragraph Number 18.]  
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Dataset heterogeneity 
Roughly a fourth of the data originates from studies involving intermittent hypoxia (Table 2). 
We were not able to detect any significant differences when the two hypoxic exposures were 
compared in the random-effects model. On the other hand, Monte-Carlo analysis revealed that 
when the data obtained from intermittent hypoxic exposure was removed from the analysis, 
time to a 95% chance for an increase in RCV generally decreased with 4-7 days, particularly 
in around 3,000 m above sea-level where most of the intermittent hypoxia studies were 
performed. We recorded iron supplementation and in 72% of the studies no iron 
supplementation was performed. Levine & Stray-Gundersen 14 suggested that iron 
supplementation is needed only if iron stores are low. Parisotto et al. 16 could not find an 
effect of iron supplementation when Epo was administrated. Thus, iron availability may not 
be an issue for healthy individuals. However, it is still not straightforward to access the 
impact of iron supplementation as e.g. a majority of the studies with iron supplementation use 
intermittent hypoxia. Thus, there is a risk of co-variance between the parameters. This extends 
to possible differences between normobaric and hypobaric hypoxia, gender and the methods 
used. In general, we saw no indications that normobaric hypoxia was producing a different 
response than hypobaric hypoxia which is in accordance with our recent findings 17. Likewise 
we were not able to detect any differences between the few studies reporting only women and 
those with only men or a mixed population. What we note, however, is that to our knowledge 
no studies have looked specifically at gender differences in RCV response to altitude dwelling 
and very few studies report males and females separately. Finally, the method to estimate 
RCV may also introduce bias. According to Sawka el al. 22, CO re-breathing may 
overestimate not only the RCV but also changes in RCV after altitude exposure because of 
CO loss to myoglobin or other ironporphyrin molecules (i.e. in the liver) and according 
changes in the quantity of these molecules following altitude exposure. However, Gore et al. 9 
and Thomsen et al. 24 concluded that the two measurement were equivalent. Furthermore, CO 
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loss to myoglobin is assumed minimal (1.6 ml over 10 min8), soand even if myoglobin should 
change as a consequence of altitude exposure the effect hereof on RCV must be assumed to 
be very minimalneglectable. Finally, it is unknown if these extra-vascular iron molecules 
actually increase with hypoxic exposure. 
 
[Paragraph Number 19.]  
Conclusion 
The physiological process of red cell expansion occurs relatively slowly with only minor 
chances for an increase to occur within 2 weeks and exposure times longer than 4 weeks 
generally required. Also the accepted paradigm that altitudes < 3,000 m are sufficient to 
trigger a robust RCV should be reconsidered particularly if the initial RCV is high. This, in 
combination with a dependency on initial red cell volume, suggests that e.g. athletes may 
need to spend more time at altitude to see an effect on red cell volume than commonly 
recommended 
 
[Paragraph Number 20.]  
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Figure legends 
 
Figure 1. Red blood cell response to exposure time and altitude. Bubble size are scaled to log 
response ratio and weighted according to study sample size but to preserve presentation 
fidelity transformed with square root function. Filled bubbles indicate increased red cell 
increase while open bubbles indicate decreases.  
 
Figure 2. Red blood cell response. Data is presented in altitude and exposure quartiles. Note 
that there was a significant interaction between the effect of attitude and exposure duration 
(p<0.0001) and therefore the main effects (p-values indicated) should be interpreted with 
caution. It is, however, clear that exposure time must exceed 17 days at an altitude of more 
than 4,000 m to exert a significant effect on the oxygen carrying capacity of the blood. Data 
are weighted log response ratios with error bars indicating 95% confidence intervals. 
 
Figure 4: The effect of initial hemoglobin mass on response to hypoxic exposure. To ensure 
clarity of presentation and to avoid confounding bias, data is limited to exposure times 
between 7 and 40 days at altitudes between 3,000 and 3,500 m. On the abscissae log response 
ratios with 95% confidence intervals are presented and on the ordinate hemoglobin mass with 
standard deviations. Mean values for altitude (3,327, 3,097, 3,070 m) and exposure (21, 19, 
23 days) for the three hemoglobin mass groups (N=13, 14 and 15) are not different. 
 
 
 
